Found 48 matching trials
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC
PHASE2This is a Phase II, single-arm, open-label, multicenter clinical study aime...
Location
Beijing Cancer Hospital
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
PHASE2An Open-label, Single-arm, Phase II Clinical Study of Firmonertinib in Peri...
Location
Multiple Locations
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
PHASE2In this study, patients with EGFR/ALK wild-type, resectable locally advance...
Location
Department of Thoracic Oncology, Hangzhou Cancer Hospital
Tracheobronchial Bioengineering Using Aortic Matrices for Airway Reconstruction
N/AA technic of tracheal, carinal or bronchial transplantation using a stented...
Location
Hopital AVICENNES Service de Chirurgie Thoracique
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
NAThis multicenter prospective clinical study focuses on elderly patients wit...
Location
Peking University People's Hospital
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage
NAThe main purpose of this study is to compare the effects of neoadjuvant wit...
Location
Shanghai Pulmonary Hospital
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NA\*Study Overview This study is investigating a surgical approach for patien...
Location
Shanghai General Hospital Thoracic Surgery Department
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function
NAThis clinical study is evaluating different treatment options for patients ...
Status
Active Not Recruiting
Location
Lithuanian University of Health Sciences Kaunas Clinics
A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC
PHASE2Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Location
Shanghai Pulmonary Hospital
The Tracking Molecular Evolution for NSCLC (T-MENC) Study
N/ATumor genomic clonal evolution assessed with liquid biopsy of stage IB,II a...